Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

被引:153
作者
De Feo, Donatella [1 ,2 ]
Merlini, Arianna [1 ,2 ]
Laterza, Cecilia [1 ]
Martino, Gianvito [1 ,2 ]
机构
[1] Hosp San Raffaele, Div Neurosci, Neuroimmunol Unit, Inst Expt Neurol INSpe,San Raffaele Sci Inst, I-20132 Milan, Italy
[2] Univ Vita Salute, San Raffaele Sci Inst, Dept Neurol & Neurophysiol, Milan, Italy
关键词
bystander effect; cell replacement; neural stem/precursor cells; neurodegeneration; neuroinflammation; therapeutic plasticity; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; FUNCTIONAL DOPAMINERGIC-NEURONS; MULTIPLE-SCLEROSIS; PRECURSOR CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; PROGENITOR-CELLS; REGENERATIVE MEDICINE; SUBVENTRICULAR ZONE; HUNTINGTONS-DISEASE;
D O I
10.1097/WCO.0b013e328352ec45
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. Recent findings Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules - for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules - whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. Summary Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.
引用
收藏
页码:322 / 333
页数:12
相关论文
共 106 条
[1]   Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta Stone [J].
Aboody, Karen ;
Capela, Alexandra ;
Niazi, Nilofar ;
Stern, Jeffrey H. ;
Temple, Sally .
NEURON, 2011, 70 (04) :597-613
[2]   Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas [J].
Aboody, KS ;
Brown, A ;
Rainov, NG ;
Bower, KA ;
Liu, SX ;
Yang, W ;
Small, JE ;
Herrlinger, U ;
Ourednik, V ;
Black, PM ;
Breakefield, XO ;
Snyder, EY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12846-12851
[3]   Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis [J].
Aharonowiz, Michal ;
Einstein, Ofira ;
Fainstein, Nina ;
Lassmann, Hans ;
Reubinoff, Benjamin ;
Ben-Hur, Tamir .
PLOS ONE, 2008, 3 (09)
[4]   Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient [J].
Amariglio, Ninette ;
Hirshberg, Abraham ;
Scheithauer, Bernd W. ;
Cohen, Yoram ;
Loewenthal, Ron ;
Trakhtenbrot, Luba ;
Paz, Nurit ;
Koren-Michowitz, Maya ;
Waldman, Dalia ;
Leider-Trejo, Leonor ;
Toren, Amos ;
Constantini, Shlomi ;
Rechavi, Gideon .
PLOS MEDICINE, 2009, 6 (02) :221-231
[5]   Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain [J].
Andres, Robert H. ;
Horie, Nobutaka ;
Slikker, William ;
Keren-Gill, Hadar ;
Zhan, Ke ;
Sun, Guohua ;
Manley, Nathan C. ;
Pereira, Marta P. ;
Sheikh, Lamiya A. ;
McMillan, Erin L. ;
Schaar, Bruce T. ;
Svendsen, Clive N. ;
Bliss, Tonya M. ;
Steinberg, Gary K. .
BRAIN, 2011, 134 :1777-1789
[6]   Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease-Is It Now Ready for Prime Time? [J].
Atkins, Harold L. ;
Muraro, Paolo A. ;
van Laar, Jacob M. ;
Pavletic, Steven Z. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) :S177-S183
[7]   Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms [J].
Bacigaluppi, Marco ;
Pluchino, Stefano ;
Jametti, Luca Peruzzotti ;
Kilic, Ertugrul ;
Kilic, Uelkan ;
Salani, Giuliana ;
Brambilla, Elena ;
West, Mark J. ;
Comi, Giancarlo ;
Martino, Gianvito ;
Hermann, Dirk M. .
BRAIN, 2009, 132 :2239-2251
[8]   Stem cell therapy for myelin diseases [J].
Ben-Hur, T ;
Einstein, O ;
Bulte, JWM .
CURRENT DRUG TARGETS, 2005, 6 (01) :3-19
[9]   Prospects of Cell Therapy for Disorders of Myelin [J].
Ben-Hur, Tamir ;
Goldman, Steven A. .
YEAR IN NEUROLOGY 2008, 2008, 1142 :218-249
[10]  
Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193